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Dear  Editor,
It  was  really  gratifying  for  me  --  I,  who  am  the  true  autho
of  the  ultimate  local  anesthetic  agent  obtained  worldwide
the  enantiomeric  mixture  of  bupivacaine  (EMB)  or  simoca
or  also  novabupi  --  the  efﬁcacy,  without  the  correspond
ing  cardiotoxicity  of  this  product,  thanks  to  the  researc
of  my  colleagues  at  the  Department  of  Anesthesia,  Hospit
de  Clinicas,  USP  (where  I  come  from).
The  method  used  in  the  research  is  based  on  the  measure
ment  of  important  variables  for  the  plexus  block  technique
which  ensures  the  great  relevance  of  such  a  research.  There
fore,  it  is  a  well-conducted  clinical  work,  able  to  endors
my  ﬁndings  in  the  preclinical  phase  of  the  study  of  th
compound  on  the  aspects  of  efﬁcacy/safety.
However,  some  inconsistencies  emerge  in  the  writing  o
this  article,  such  as:
(a)  The  authors,  when  referring  to  the  local  anesthetic  com
pared  to  ropivacaine,  committed  a  historical  untruth.
The  invention  that  resulted  in  the  non-equimola
racemic  compound  formed  by  antagonistic  isome
--  the  bupivacain  enantiomers  (S75%:R25%)  WAS  NO
‘‘created  by  a  Brazilian  pharmaceutical  company
at  all.
In truth,  the  insight  happened  in  the  stands  of  m
lab  at  the  Department  of  Pharmacology,  Institute  of
Biomedical  Sciences,  University  of  São  Paulo,  and  it  was
also  there  that  I  made  the  application  for  patenting.
As  a  support  for  this  historical  truth,  this  product  was
endorsed  by  INPI  (Instituto  Nacional  de  Propriedade
Industrial)  --  the  regulatory  agency  of  the  Brazilian
government  --  which  granted  it  a  patentand  recently  conﬁrmed  it  by  charte
(Fig.  1).
In  the  course  of  writing  the  article,  however,  ther
is  a  reference  to  this  compound,  attributing  its  or
gin  to  the  ‘‘Brazilian  pharmacology,  that  introduced  a
enantiomeric  mixture  of  optical  isomers  containing  75
levobupivacaine  (S-)  and  25%  dextrobupivacaine  (R+)  
the  S75-R25  bupivacaine’’’.
My  question  is:  What  is  the  group  of  pharmacologis
responsible  for  this  feat?  This  was  not  mentioned.
And  why  the  true  authorship  was  omitted,  even  at  th
cost  of  blurring  the  University  of  Sao  Paulo?  The  questio
remains  hanging  in  the  air.
Would  not  be  more  correct  to  search  the  literature
so  as  not  to  incur  in  an  enormous  blunder  which  impai
the  excellence  of  the  research  and  thus  shakes  someho
the  reputation  of  the  authors  (some  of  them  renowne
Professors)?  In  a  quick  search  of  the  literature,  it  wou
be  possible  to  ﬁnd  reliable  studies  (among  others)  an
relevant  and  trustworthy  papers,  such  as:
1.  Simonetti  MPB,  Ferreira  FMC.  Do  the  d-isome
of  bupivacaíne  contribute  to  the  improvement  o
efﬁcacy  in  neural  block?  Reg  Anesth  Paim  Med
1999;24(suppl.):43.
2.  Simonetti  MPB  et  al.  Is  it  worth  manipulating  th
enantiomeric  ratio  of  bupivacaine  to  improve  th
efﬁcacy  of  the  neural  block  with  reduced  ca
diotoxicidaty?  Inter  Monitor-ESRA.  1999;11(suppl.
198.
3.  Simonetti  MPB.  Anestésicos  locais  espinhais  levó
giros.  In  anestesia  peridural,  atualizac¸ão  e  perspe
tivas:  Delﬁno  J,  Vale  Nilton.  Anestesia  peridura
atualizac¸ão  e  perspectivas.  São  Paulo:  Editor
Atheneu.  2000:81--97.
4.  Simonetti  MPB.  A  epopeia  do  desenvolvimento  dos
anestésicos  locais  em  curso  de  educac¸ão  a  distância
em  anestesiologia.  Editores:  Carraretto  A,  Viana  P.
2007,  vol.  VII,  p.  162--178.
5.  Simonetti  MPB.  Patente:  curiosidades  vernáculas  e
história  da  ideia  que  foi  patenteada  e  da  patente
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Figure  1  Charter.
que  não  foi  concedida.  Anestesia  em  Revista,
2013;2:9--21.
 Meanwhile,  the  chemical  name  with  which  my  anes-
thetic  was  baptized  by  the  company  that  sells  it  has
caused  embarrassing  situations.  I  called  him  Simocain
to  current  nomenclature.  However,  all  that  happened
was  beyond  my  control,  because  my  invention  has
been  transferred  by  USP  to  the  Company  selling  it;
and  the  compound  received  an  inappropriate  name,
difﬁcult  to  be  cited  in  scientiﬁc  articles  by  being(S  from  left  and  caine, a  sufﬁx  used  by  Neumamm  for
the  crystals  of  Erytroxilon  coca  leaves  and  adopted  for
all  local  anesthetics  obtained  since  1855),  accordingtoo  long,  since  it  encompasses  all  pharmacotechnique:
levobupivacaine  hydrochloride  in  enantiomeric  excess
5%,  75  to  25%... Whew!  Hence  the  simpliﬁcation  that
220  R
Brazilian  researchers  are  now  using  --  calling  levobupi-
vacaine  (which  is  another  local  anesthetic,  homochiral,
Chirocaine)  to  the  non-equimolar  racemic  product  of
bupivacain  -- the  Brazilian  local  anesthetic.  I  insist  that
the  agent  levobupivacaine  obtained  by  Chirosciences  by
means  of  resolution  of  the  equimolar  racemate  NEVER
existed  commercially  in  Brazil.
(c)  Consequences:  this  semantic  error  causes  confusion  to
the  ‘‘referees’’’,  mainly  foreign  ones,  since  there  are
signiﬁcant  differences,  for  instance,  pharmacodynamic
and  pharmacokinetic  ones,  between  simocain  (which
is  racemic)  and  levobupivacaine  (which  is  homochiral);
moreover,  there  are  also  stereoselective  differences.
There  is  another  aggravating  circumstance:  the  Brazil-
ian  anesthetic  --  Simocain  --  cannot  be  compared  with
results  of  researches  in  which  homochiral  levobupiva-
caine  was  effectively  used,  by  the  way  of  conclusion.
It  would  be  like  comparing  completely  different  enti-
ties,  or  apples  with  pears...  More  importantly,  of  course
this  inadequacy  about  the  nomenclature  can  adversely
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3.affect  the  Brazilian  research,  if  there  was  a  pretens
of  submitting  papers  to  journals  abroad  (if  the  error  
detected!!!).  On  the  other  hand,  this  is  a  bad  examp
to  our  young  fellow  researchers,  who  would  have  to  liv
together  with  false  data...  And  if  that  was  not  enough
this  error  affects  the  authors’  reputation  of  excellenc
and  ‘‘bypass’’’  the  merits  of  USP.  And  further,  the  erro
discredits  the  RBA  and  its  Editorial  Board  (by  allowin
that  such  impropriety  is  published),  because  our  jou
nal,  being  bilingual,  has  broadened  its  horizons  beyon
Brazilian  borders.  We  must  consider  the  interest  o
Turkish  authors,  who  have  embarked  on  this  sophistr
drawing  on  quotations  from  Brazilian  studies  in  whic
the  nomenclature  of  the  anesthetic  is  incorrect.  Alon
the  same  lines  and  for  the  reasons  already  explained
pure  levobupivacaine  should  not  be  the  basis  for  thLETTERS  TO  THE  EDITO
results  of  S75-R25  as  usually  the  case  with  many  paper
including  the  article  in  question.
I  hope  that  the  USPian  authors  recognize  the  error  o
this  omission  to  the  University  of  Sao  Paulo  -  which  was  th
birthplace  for  the  ﬁrst  and  only  patent  granted  to  Brazilia
regional  anesthesia!
Now  I  want  to  invoke  the  great  physiologist  Ramon  
Cajal,  Nobel  Prize  1906,  with  a  transcript  of  his  messag
--  a  true  libel  in  defence  of  intellectual  property  and  sure
of  great  value  for  the  reﬂection  of  master  trainers  of  anae
thesiologists  and  medical  researchers:
‘‘By  being  a  victim  of  annoying  omissions  and  of  unju
silences,  we  realize  that  every  idea  is  a  scientiﬁc  cre
ture,  whose  author,  who  gave  it  his  life  to  the  cost  o
great  fatigue,  cries  when  seeing  his  paternity  disavowed
with  the  same  cry  of  that  mother  who  saw  snatched  fro
her  arms  the  fruit  of  her  womb.’’1
I  hope  I  have  contributed  without  intending  anythin
other  than  the  truth,  because  as  a  professional  I  am  we
known  and,  in  addition,  well-paid  with  due  royalties.
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